Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on NASH Therapeutics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN117964557A offers high-yield Resmetirom intermediate synthesis. Reduces impurities and avoids column chromatography for cost-effective manufacturing.
Overcome low yields and high costs in obeticholic acid synthesis. Discover emerging catalytic methods avoiding Pd/C. Find trusted suppliers for GMP-compliant API production.